Saol International Limited
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $826,873 | 169 | 76.5% |
| Royalty or License | $208,884 | 5 | 19.3% |
| Consulting Fee | $45,623 | 17 | 4.2% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: (DCA/PDCD) | $678,514 | 1 | 167 |
| Glioblastoma additional indication | $100,000 | 0 | 1 |
| Evaluation of Antibody-Dependent Cellular Cytotoxicity (ADCC) Antibodies in VARIZIG | $48,359 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Physical Medicine & Rehabilitation | $24,723 | 2 | $12,361 |
| Pediatrics | $15,000 | 1 | $15,000 |
| Infectious Disease | $1,000 | 1 | $1,000 |
| Endocrinology, Diabetes & Metabolism | $863.79 | 1 | $863.79 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Zachary Mccormick, M.d, M.D | Physical Medicine & Rehabilitation | Chicago, IL | $19,113 | $0 |
| Stuart Adler, Md, MD | Pediatrics | Richmond, VA | $15,000 | $0 |
| Sheng Li, Md, Phd, MD, PHD | Physical Medicine & Rehabilitation | Houston, TX | $5,610 | $0 |
| Unknown Provider | — | — | $4,400 | $0 |
| David Snydman, Md, MD | Infectious Disease | Boston, MA | $1,000 | $0 |
| Dr. Peter Stacpoole, Md, MD | Endocrinology, Diabetes & Metabolism | Gainesville, FL | $863.79 | $0 |
| Unknown Provider | — | — | $500.00 | $0 |
Top Products
- Dichloroacetate $78,150
- VariZig $48,359
Associated Products (2)
- Dichloroacetate $78,150
- VariZig $62,067
Payment Categories
- Consulting $45,623
- Research $826,873
- Royalties $208,884
About Saol International Limited
Saol International Limited has made $1.1M in payments to 7 healthcare providers, recorded across 191 transactions in the CMS Open Payments database. In 2022, the company paid $37,119. The top product by payment volume is Dichloroacetate ($78,150).
Payments were distributed across 4 medical specialties. The top specialty by payment amount is Physical Medicine & Rehabilitation ($24,723 to 2 doctors).
Payment categories include: Consulting ($45,623), Research ($826,873), Royalties ($208,884).
Saol International Limited is associated with 2 products in the CMS Open Payments database.